[144] UNITED STATES ANTIMONY CORP SEC Filing

Rhea-AI Filing Summary

Form 144 filing for UNITED STATES ANTIMONY CORP (UAMY) reports a proposed sale of 50,000 common shares through Merrill Lynch in New York with an aggregate market value of $365,791.80 and an approximate sale date of 10/01/2025. The filer reports acquiring 135,000 of the shares on 08/14/2024 in an open market purchase paid in cash. The issuer has 128,727,843 shares outstanding as stated. The notice includes the filer’s representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Compliance disclosure: The filer submitted a Form 144 providing required public notice of a proposed sale under Rule 144.
• Acquisition paid in cash: The shares to be sold were acquired on 08/14/2024 via open-market purchase and paid in cash, as disclosed.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice showing a planned sale of 50,000 shares; acquisition was an open-market purchase.

The filing documents a proposed sale under Rule 144 of 50,000 common shares with an aggregate market value of $365,791.80 and an approximate sale date of 10/01/2025. The filer previously acquired 135,000 shares on 08/14/2024 via open-market purchase paid in cash. Relative to the stated 128,727,843 shares outstanding, the proposed sale is a very small percentage of outstanding equity, and the filing itself is a compliance disclosure rather than an operational event.

Corporate Governance Expert

TL;DR: The Form 144 appears complete and serves as a public compliance disclosure of a planned insider sale.

The document contains required disclosures: broker name (Merrill Lynch One Bryant Park), number of shares to be sold (50,000), acquisition details (08/14/2024 open-market purchase of 135,000 shares), and a statement that no undisclosed material adverse information is known to the filer. This preserves transparency around insider selling activity and meets Rule 144 notification expectations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch One Bryant Park 48th Fl New York NY 10036	50000	365791.8	128727843	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/14/2024	OPEN MARKET PURCHASE	OPEN MARKET			135000	08/14/2024	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for UAMY disclose about the proposed sale?

The filing discloses a proposed sale of 50,000 common shares through Merrill Lynch with an aggregate market value of $365,791.80 and an approximate sale date of 10/01/2025.

When and how were the shares being sold acquired according to the filing?

The filing states the shares were acquired on 08/14/2024 in an open-market purchase, with 135,000 shares acquired and payment in cash.

How many shares of the issuer are outstanding as reported in the Form 144?

The filing reports 128,727,843 shares outstanding.

Which broker is named in the Form 144 for the proposed sale?

The broker named is Merrill Lynch One Bryant Park, 48th Fl, New York, NY 10036.

Does the filer state any undisclosed material information about the issuer?

The filer represents by signing the notice that they do not know any material adverse information